➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Colorcon
Dow
McKesson
Mallinckrodt

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

DEPO-TESTOSTERONE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Depo-testosterone, and what generic alternatives are available?

Depo-testosterone is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in DEPO-TESTOSTERONE is testosterone cypionate. There are sixty-nine drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the testosterone cypionate profile page.

US ANDA Litigation and Generic Entry Outlook for Depo-testosterone

A generic version of DEPO-TESTOSTERONE was approved as testosterone cypionate by WEST-WARD PHARMS INT on July 15th, 2010.

  Start Trial

Drug patent expirations by year for DEPO-TESTOSTERONE
Drug Prices for DEPO-TESTOSTERONE

See drug prices for DEPO-TESTOSTERONE

Recent Clinical Trials for DEPO-TESTOSTERONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Brooks RehabilitationPhase 2
North Florida/South Georgia Veterans Health SystemPhase 2
North Florida Foundation for Research and EducationPhase 2

See all DEPO-TESTOSTERONE clinical trials

Pharmacology for DEPO-TESTOSTERONE
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists

US Patents and Regulatory Information for DEPO-TESTOSTERONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn DEPO-TESTOSTERONE testosterone cypionate INJECTABLE;INJECTION 085635-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn DEPO-TESTOSTERONE testosterone cypionate INJECTABLE;INJECTION 085635-002 Approved Prior to Jan 1, 1982 AO RX No Yes   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn DEPO-TESTOSTERONE testosterone cypionate INJECTABLE;INJECTION 085635-003 Approved Prior to Jan 1, 1982 AO RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Johnson and Johnson
McKinsey
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.